CONMED Revenue 2010-2022 | CNMD

CONMED revenue from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
CONMED Annual Revenue
(Millions of US $)
2021 $1,011
2020 $862
2019 $955
2018 $860
2017 $796
2016 $764
2015 $719
2014 $740
2013 $763
2012 $767
2011 $725
2010 $714
2009 $695
CONMED Quarterly Revenue
(Millions of US $)
2022-06-30 $277
2022-03-31 $242
2021-12-31 $274
2021-09-30 $249
2021-06-30 $255
2021-03-31 $233
2020-12-31 $253
2020-09-30 $238
2020-06-30 $158
2020-03-31 $214
2019-12-31 $265
2019-09-30 $234
2019-06-30 $238
2019-03-31 $218
2018-12-31 $242
2018-09-30 $202
2018-06-30 $213
2018-03-31 $202
2017-12-31 $223
2017-09-30 $190
2017-06-30 $197
2017-03-31 $187
2016-12-31 $204
2016-09-30 $185
2016-06-30 $193
2016-03-31 $181
2015-12-31 $191
2015-09-30 $169
2015-06-30 $181
2015-03-31 $178
2014-12-31 $195
2014-09-30 $175
2014-06-30 $188
2014-03-31 $182
2013-12-31 $203
2013-09-30 $179
2013-06-30 $193
2013-03-31 $187
2012-12-31 $201
2012-09-30 $182
2012-06-30 $190
2012-03-31 $194
2011-12-31 $186
2011-09-30 $173
2011-06-30 $183
2011-03-31 $183
2010-12-31 $184
2010-09-30 $172
2010-06-30 $181
2010-03-31 $176
2009-12-31 $191
2009-09-30 $175
2009-06-30 $165
2009-03-31 $164
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.967B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
McKesson (MCK) United States $50.991B 14.81
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
Invacare (IVC) United States $0.033B 0.00